Year: 2023

OTTAWA BANCORP, INC. Announces Third Quarter 2023 Results

Written by Customer Service on November 13, 2023. Posted in Earnings Releases And Operating Results.

OTTAWA, Ill., Nov. 13, 2023 (GLOBE NEWSWIRE) — Ottawa Bancorp, Inc. (the “Company”) (OTCQX: OTTW), the holding company for OSB Community Bank (the “Bank”), announced net income of $0.5 million, or $0.20 per basic and diluted common share for the three months ended September 30, 2023, compared to net income of $0.3 million, or $0.13 per basic and diluted common share for the three months ended September 30, 2022. For the nine months ended September 30, 2023, the Company announced net income of $1.5 million, or $0.58 per basic and diluted common share, compared to net income of $1.9 million, or $0.73 per basic and diluted common share for the nine months ended September 30, 2022. The loan portfolio, net of allowance, increased to $313.5 million as of September 30, 2023 from $307.7 million as of December 31, 2022 as originations of...

Navigator Holdings Ltd. Third Quarter 2023 Results (Unaudited)

Written by Customer Service on November 13, 2023. Posted in Earnings Releases And Operating Results.

LONDON, Nov. 13, 2023 (GLOBE NEWSWIRE) — HighlightsOn November 13, 2023, the Board declared a cash dividend of $0.05 per share of the common stock of Navigator Holdings Ltd. (the “Company”, “Navigator”, “we”, “our” and “us”) (NYSE: NVGS), for the quarter ended September 30, 2023 (the “Dividend”). The Dividend will be payable on December 21, 2023, to all shareholders of record as of the close of business New York time on December 7, 2023 which would have equated to a quarterly dividend payment of $3.7 million. As part of the Capital Return Policy for the quarter ended September 30, 2023, Navigator expects to repurchase approximately $1.1 million of the Company’s common stock (the “Share Repurchases”) between November 16, 2023 and December 31, 2023, subject to operating needs, market...

Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Written by Customer Service on November 13, 2023. Posted in Earnings Releases And Operating Results.

DALLAS, Nov. 13, 2023 (GLOBE NEWSWIRE) — Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today reported its third quarter 2023 financial results and provided a corporate update. Recent Highlights and Anticipated Milestones:Presented novel preclinical data at SITC 2023 Annual Meeting demonstrating that its CoStimulatory Antigen Receptor (CoStAR) enhances activity of CD4+ T cells in multiple ways to broaden anti-tumor response and support CD8+ T cells Publication of ITIL-306 manuscript in Frontiers in Immunology (https://www.frontiersin.org/articles/10.3389/fimmu.2023.1256491/full), demonstrating that CoStAR enhances T cell activity and augments tumor reactivity of TILs in preclinical...

Avicanna Announces Appointment of Paul Fornazzari to Board of Directors

Written by Customer Service on November 13, 2023. Posted in Public Companies.

TORONTO, Nov. 13, 2023 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the commercialization of proprietary cannabinoid-based products and a medical cannabis care platform is pleased to announce the appointment of Paul Fornazzari to the board of directors. Paul Fornazzari is a business executive, securities lawyer, and board director with over twenty-five years of experience with growth-stage and established Canadian and international companies. Mr. Fornazzari is also a Partner focusing on Securities and Corporate Finance with Fasken Martineau DuMoulin (“Fasken”) one of Canada’s largest law firms with a well recognized domestic and international practice. In addition to English, Mr. Fornazzari is a fluent Spanish speaker from Latin America. “I...

Atlantic American Corporation Reports Third Quarter Results for 2023

Written by Customer Service on November 13, 2023. Posted in Earnings Releases And Operating Results.

ATLANTA, Nov. 13, 2023 (GLOBE NEWSWIRE) — Atlantic American Corporation (Nasdaq- AAME) today reported net income of $1.8 million, or $0.08 per diluted share, for the three month period ended September 30, 2023, compared to net loss of $0.7 million, or $(0.04) per diluted share, for the three month period ended September 30, 2022. The Company had net income of $2.1 million, or $0.09 per diluted share, for the nine month period ended September 30, 2023, compared to net income of $0.5 million, or $0.01 per diluted share, for the nine month period ended September 30, 2022. The increase in net income for the three and nine month periods ended September 30, 2023 was primarily the result of a more favorable loss experience in the life and health operations, from the comparable periods in 2022, coupled with a decrease in unrealized losses...

BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results

Written by Customer Service on November 13, 2023. Posted in Earnings Releases And Operating Results.

Company to Host a Conference Call and Webcast on November 14, 2023, at 10:30 am EDT POMPANO BEACH, Fla., Nov. 13, 2023 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today reported financial results for the quarter ended September 30, 2023. Jason Matuszewski, Chief Executive Officer of BioStem Technologies Inc. said, “2023 has been a remarkable year of growth and milestones for our organization, we are excited to share our latest achievements, innovations, and strategic partnerships that continue to drive our mission of advancing the development, manufacture, and commercialization of cutting-edge placental-derived allografts for advanced wound care. In this earnings call, we will delve...

SCYNEXIS Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Written by Customer Service on November 13, 2023. Posted in Earnings Releases And Operating Results.

IND enabling development activities for SCY-247, the next generation fungerp from SCYNEXIS’ proprietary antifungal platform, continue to advance Remediation strategies following the voluntary recall of BREXAFEMME® and the MARIO study clinical hold are being evaluated With cash, cash equivalents and investments of $105.2 million as of September 30, 2023, SCYNEXIS projects a cash runway of more than two yearsJERSEY CITY, N.J., Nov. 13, 2023 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today reported financial results for the third quarter ended September 30, 2023. “We faced unexpected challenges associated with the recent BREXAFEMME® recall and the clinical hold placed on the MARIO trial this quarter,”...

Star Bulk Carriers Corp. Reports Net Profit of $43.7 Million for the Third Quarter of 2023, and Declares Quarterly Dividend of $0.22 Per Share

Written by Customer Service on November 13, 2023. Posted in Earnings Releases And Operating Results.

ATHENS, Greece, Nov. 13, 2023 (GLOBE NEWSWIRE) — Star Bulk Carriers Corp. (the “Company” or “Star Bulk”) (Nasdaq: SBLK), a global shipping company focusing on the transportation of dry bulk cargoes, today announced its unaudited financial and operating results for the third quarter of 2023. Unless otherwise indicated or unless the context requires otherwise, all references in this press release to “we,” “us,” “our,” or similar references, mean Star Bulk Carriers Corp. and, where applicable, its consolidated subsidiaries. Financial Highlights(Expressed in thousands of U.S. dollars, except for daily rates and per share data) Third quarter 2023 Third quarter 2022 Nine months ended September 30, 2023 Nine months ended September 30, 2022Voyage Revenues $223,087 $364,136 $685,808 $1,142,353Net...

ECN Capital Reports US$0.00 in Adjusted Net Income per Common Share in Q3-2023

Written by Customer Service on November 13, 2023. Posted in Earnings Releases And Operating Results.

TORONTO, Nov. 13, 2023 (GLOBE NEWSWIRE) — ECN Capital Corp. (TSX: ECN) (“ECN Capital” or the “Company”) today reported financial results for the three-month period ended September 30, 2023. For the three-month period ended September 30, 2023, ECN Capital reported Adjusted net income applicable to common shareholders from continuing operations of $0.5 million or $0.00 per share (basic) versus $0.7 million or $0.00 per share (basic) for the previous three-month period and $11.8 million or $0.05 per share (basic) for the same period last year. “Skyline’s strategic investment in ECN closed in the quarter and we began developing the new products and services needed to launch the Champion Financing JV in early 2024.”, said Steven Hudson, CEO of ECN Capital Corp. “Separately, the corporate simplification plan announced last quarter is...

First Watch Announces Acquisition of Six Franchise Restaurants in Florida

Written by Customer Service on November 13, 2023. Posted in Mergers And Acquisitions.

BRADENTON, Fla., Nov. 13, 2023 (GLOBE NEWSWIRE) — First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept, announced that it has acquired, effective today, six of its previously franchise-owned restaurants in Florida. “We’re thrilled to welcome our newest teams in the Florida Panhandle to the First Watch company-owned system. These franchise partners have served the community from Destin to Tallahassee for more than a decade, and we are thankful for their dedication and help in a successful transition,” said Chris Tomasso, First Watch CEO and President. “As part of our long-term growth strategy, we’ve now welcomed 23 new restaurants this year alone into the First Watch fold that were previously owned by our franchise partners. We look forward to celebrating our newest...

Year: 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals